2026 ICD-10-CM Diagnosis Code T39.2X2APoisoning by pyrazolone derivatives, intentional self-harm, initial encounter

ICD-10-CM CodesS00–T88T36-T50T39

ICD-10-CM T39.2X2A
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

T39.2X2A is a billable ICD-10-CM diagnosis code for poisoning by pyrazolone derivatives, intentional self-harm, initial encounter. The 7th character A marks it as an initial encounter code, used while the patient is receiving active treatment. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 917 through 918. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under External cause codes: intent of injury, self-harm; External cause codes: poisoning by drug; and Poisoning by drugs, initial encounter.

Code Identity

ICD-10-CM Code
T39.2X2A
Billable Status
Yes — Valid for Submission
Code Describes
Poisoning by pyrazolone derivatives, intentional self-harm, initial encounter
Short Description
Poisoning by pyrazolone derivatives, self-harm, init
Parent Code
Poisoning by pyrazolone derivatives, intentional self-harm

Code Classification

ChapterS00–T88Injury, poisoning and certain other consequences of external causes
SectionT36-T50Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
CategoryT39Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics
This CodeT39.2X2APoisoning by pyrazolone derivatives, intentional self-harm, initial encounter

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Azapropazone overdose
  • Azapropazone poisoning
  • Dichloralphenazone poisoning
  • Intentional azapropazone overdose
  • Intentional azapropazone poisoning
  • Intentional dichloralphenazone poisoning
  • Intentional oxyphenbutazone overdose
  • Intentional oxyphenbutazone poisoning
  • Intentional phenylbutazone overdose
  • Intentional phenylbutazone poisoning
  • Oxyphenbutazone overdose
  • Oxyphenbutazone poisoning
  • Phenylbutazone overdose
  • Poisoning by phenylbutazone

Coding GuidelinesGuidance

When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined). If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics (T39). Use the following options for the applicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR EXT021
External cause codes: intent of injury, self-harm
Default principal diagnosis: inpatient No · outpatient No
CCSR EXT014
External cause codes: poisoning by drug
Default principal diagnosis: inpatient No · outpatient No
CCSR INJ022
Poisoning by drugs, initial encounter
Default principal diagnosis: inpatient No · outpatient No
CCSR MBD012
Suicidal ideation/attempt/intentional self-harm
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Aminopyrine

    a pyrazolone with analgesic, anti-inflammatory, and antipyretic properties but has risk of agranulocytosis. a breath test with 13c-labeled aminopyrine has been used as a non-invasive measure of cytochrome p-450 metabolic activity in liver function tests.
  • Aminopyrine N-Demethylase

    a pyrazolone with analgesic, anti-inflammatory, and antipyretic properties but has risk of agranulocytosis. a breath test with 13c-labeled aminopyrine has been used as a non-invasive measure of cytochrome p-450 metabolic activity in liver function tests.
  • Antipyrine

    an analgesic and antipyretic that has been given by mouth and as ear drops. antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (from martindale, the extra pharmacopoeia, 30th ed, p29)
  • Dipyrone

    a drug that has analgesic, anti-inflammatory, and antipyretic properties. it is the sodium sulfonate of aminopyrine.
  • Feprazone

    a pyrazole that has analgesic, anti-inflammatory, and antipyretic properties. it has been used in mild to moderate pain, fever, and inflammation associated with musculoskeletal and joint disorders. (from martindale, the extra pharmacopoeia, 30th ed, p15)
  • Oxyphenbutazone

    a non-steroidal anti-inflammatory drug. oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (from ama, drug evaluations annual, 1994, p2000) it had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (from martindale, the extra pharmacopoeia, 30th ed, p27)
  • Phenylbutazone

    a butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. it has been used in ankylosing spondylitis; rheumatoid arthritis; and reactive arthritis.

Table of Drugs and ChemicalsClinical

Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.

SubstanceAccidentalSelf-harmAssaultUndeter­minedAdverse
Effect
Under­dosing
AmidopyrineT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
AminofenazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
AminophenazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
AminopyrineT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
AnalginT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
AntipyrineT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
AzapropazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
ButazolidinT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
ClofezoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
DiphenylbutazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
DipyroneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
FenazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
FenylbutazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
FeprazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
HydroxyphenylbutazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
IndocinT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
IsopropylaminophenazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
KebuzoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
KetazonT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Metamizole sodiumT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
MethampyroneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
MofebutazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
MonophenylbutazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Myochrysin (e)T39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
NifenazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
NoramidopyrineT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Noramidopyrine::methanesulfonate sodiumT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
OxyphenbutazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
PhenazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
PhenylT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Phenyl::butazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Phenyl::enediamineT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Phenyl::hydrazineT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Phenyl::hydrazine::antineoplasticT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Phenyl::mercuric compoundsT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Phenyl::salicylateT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
PhenylbutazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
PropyphenazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
PyramidonT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Pyrazole (derivatives)T39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Pyrazolone analgesic NECT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
RamifenazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
SulfamazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
SulfamidopyrineT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
SulpyrineT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
SuxibuzoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Tandearil, tanderilT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6

Patient EducationClinical

Poisoning

A poison is any substance that is harmful to your body. You might swallow it, inhale it, inject it, or absorb it through your skin. Any substance can be poisonous if too much is taken. Poisons can include:

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert T39.2X2A to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
965.5 Poisoning-pyrazole deriv
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.
ICD-9-CM
E950.0 Poison-analgesics
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About T39.2X2AOverview

Is T39.2X2A (Poisoning by pyrazolone derivatives, intentional self-harm) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report poisoning by pyrazolone derivatives, intentional self-harm, initial encounter on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What does the 7th character A in T39.2X2A mean?

The final character A marks the initial encounter: use it while the patient is receiving active treatment for poisoning by pyrazolone derivatives, intentional self-harm, such as an emergency visit or first evaluation.

What MS-DRG does T39.2X2A group to?

When poisoning by pyrazolone derivatives, intentional self-harm, initial encounter is the principal diagnosis on an inpatient stay, it groups to MS-DRG 917, 918, with relative weights from 0.8571 to 1.5684 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of T39.2X2A?

Under the General Equivalence Mappings, poisoning by pyrazolone derivatives, intentional self-harm, initial encounter converts to ICD-9-CM 965.5 (poisoning-pyrazole deriv) and E950.0 (poison-analgesics). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.